Document Detail

Rod and cone function in patients with KCNV2 retinopathy.
Jump to Full Text
MedLine Citation:
PMID:  23077521     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: To investigate rod and cone function and disease mechanisms in patients with KCNV2 retinopathy.
METHODOLOGY/PRINCIPAL FINDINGS: Psychophysical examinations as well as detailed electrophysiological examinations with Ganzfeld and multifocal electroretinogram (ERG) were performed to study response dynamics. Additionally, fundus photography, autofluorescence imaging and spectral domain OCTs were carried out for morphological characterization. Molecular genetic analysis revealed compound heterozygosity in five patients and homozygosity for the KCNV2 gene in one patient. The mutations resulted in complete absence of Kv8.2 subunits in three patients (no protein group, NOP), while the other three patients expressed mutant Kv8.2 subunits resulting in altered Kv2.1/Kv8.2 heteromeric or residual Kv2.1 homomeric potassium channel function (altered protein group, ALP). Although more advanced morphological changes were visible in the NOP group, a clear functional difference between the two groups could not be observed. All patients showed characteristic dynamics of the b-wave intensity-response function, however, scotopic b-wave response amplitudes were within normal limits. We also observed severely reduced oscillatory potentials.
CONCLUSIONS/SIGNIFICANCE: A specific genotype-phenotype correlation in retinal function could not be demonstrated. KCNV2 mutations cause a unique form of retinal disorder illustrating the importance of K(+)-channels for the resting potential, activation and deactivation of photoreceptors, while phototransduction remains unchanged. The reduced oscillatory potentials further suggest an altered function of the inner retina. Besides the characteristically steep amplitude-versus-intensity relationship, flicker responses at intermediate frequencies (5-15 Hz) are significantly reduced and shifted in phase.
Authors:
Ditta Zobor; Susanne Kohl; Bernd Wissinger; Eberhart Zrenner; Herbert Jägle
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-10-15
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-18     Completed Date:  2013-03-20     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e46762     Citation Subset:  IM    
Affiliation:
Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany. ditta.zobor@med.uni-tuebingen.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Female
Humans
Male
Middle Aged
Potassium Channels, Voltage-Gated / genetics,  physiology*
Psychophysics
Retinal Cone Photoreceptor Cells / physiology*
Retinal Diseases / physiopathology*
Retinal Rod Photoreceptor Cells / physiology*
Tomography, Optical Coherence
Chemical
Reg. No./Substance:
0/KCNV2 protein, human; 0/Potassium Channels, Voltage-Gated
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
ISSN: 1932-6203
Publisher: Public Library of Science, San Francisco, USA
Article Information
Download PDF
Copyright: 2012 Zobor et al
License:
Received Day: 24 Month: 4 Year: 2012
Accepted Day: 10 Month: 9 Year: 2012
collection publication date: Year: 2012
Electronic publication date: Day: 15 Month: 10 Year: 2012
Volume: 7 Issue: 10
E-location ID: e46762
PubMed Id: 23077521
ID: 3471896
Publisher Id: PONE-D-12-11551
DOI: 10.1371/journal.pone.0046762

Rod and Cone Function in Patients with KCNV2 Retinopathy Alternate Title:Rod and Cone Function in KCNV2 Retinopathy
Ditta Zobor1*
Susanne Kohl2
Bernd Wissinger2
Eberhart Zrenner1
Herbert Jägle13
Anneke I. den Hollanderedit1 Role: Editor
1Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany
2Molecular Genetics Laboratory, Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany
3Department of Ophthalmology, University of Regensburg, Regensburg, Germany
Radboud University Nijmegen Medical Centre, The Netherlands
Correspondence: * E-mail: ditta.zobor@med.uni-tuebingen.de
[conflict] Competing Interests: The authors have declared that no competing interests exist.
Contributed by footnote: Performed the experiments: DZ SK BW EZ HJ. Analyzed the data: DZ SK BW EZ HJ. Contributed reagents/materials/analysis tools: DZ SK BW EZ HJ. Wrote the paper: DZ. corrected the manuscript: SK BW EZ HJ.

Introduction

In 1983 Gouras et al. [1] reported an unusual type of retinal dystrophy, which was associated with characteristic alterations in the rod electroretinogram (ERG). This rare, autosomal recessive condition has been reported in several further studies [2], [3], [4], [5], [6], [7], [8], [9] and was named “cone dystrophy with supernormal rod responses (CDSRR)”. CDSRR is characterized by an early markedly reduced central visual acuity with central scotoma, photophobia, severe color disturbances, and occasionally nystagmus. In contrast to other cone dystrophies, a disease-typical alteration of the rod system could be observed: while rod sensitivity to weak flashes was reduced, an augmented responsiveness to higher levels of flash stimuli could be detected, and implicit times were considerably prolonged [1], [2], [3], [4], [5], [6], [7], [8], [9]. These characteristics were unique for CDSRR, however, the underlying disease mechanism could not be elucidated at that time.

In 2006 Wu et al [10] successfully linked the disorder to chromosome 9p24 and the KCNV2 gene, which is predominantly expressed in retinal rod and cone photoreceptors [11]. It encodes a member of voltage gated potassium channels (Kv channels), representing a silent subunit (Kv8.2) that is able to assemble with Kv2.1 to form functional heteromeric channels. This results in a shift in the steady-state activation curve of the Kv2.1 channel towards more negative potentials due to a permanent outward K+ current, a lower threshold potential for activation, a shortened activation time and slower inactivation kinetics [11], [12], [13]. A mutation in KCNV2 may thus alter important characteristics of the Ikx current that influences the photoreceptor membrane potential. However, the dysfunction and mechanisms that link KCNV2 mutations with the clinical picture still remain to be elucidated.

Over 50 different mutations in KCNV2 have been reported so far, mainly small indel mutations or point mutations that constitute protein truncation mutations and amino acid substitutions [10], [14], [15], [16]. Recently, several large deletions within or of the KCNV2 gene of up to 237 kb in size have been described [16]. Although the genetically detected patients did show altered rod responsiveness, the term “supernormal rod response” was in many cases deceptive, as previously shown [17]. The term “supernormal rod ERG” is a misnomer and most recently, the disorder has been referred to as “KCNV2 retinopathy” [18].

This study employs detailed psychophysical and electrophysiological testing as well as spectral domain optical coherence tomography (OCT) and fundus autofluorescence (FAF) to reveal novel insights into disease-specific functional changes in KCNV2 retinopathy. Additionally, we explore differences of disease specific functional aspects in the phenotype that correlate with the underlying KCNV2 gene alterations. The genotype of three patients has already been published elsewhere [19], the remaining three patients' genetic findings are presented here for the first time.


Methods
Patients

Six otherwise healthy patients of German origin (3 female and 3 male; 2 simplex cases and 2 sibling pairs; mean age: 39 years, range 28–60 years) with previously diagnosed stationary retinal disorder and known mutations in the KCNV2 gene were examined.

All examinations were carried out after written informed consent and in accordance with the Declaration of Helsinki. The study was approved by the Ethics Committee of the Medical Faculty of University of Tübingen.

Molecular Genetics

Genomic DNA was extracted from venous EDTA-blood samples according to standard procedures. Genetic testing for point mutations was performed by PCR amplification and subsequent Sanger sequencing of both coding exons and flanking intronic sequences of the KCNV2 gene, as described previously [16].

Analysis for genomic deletion was investigated by quantitative copy number analyses of the KCNV2 gene, with realtime PCR employing TaqMan technology or SYBR Green detection assays, as reported earlier [16].

Comparative genome hybridizations (CGH) using a predesigned chromosome 9 specific 385k oligonucleotide array (HG18 CHR9 FT; Roche NimbleGen Inc., Madison, WI) was performed for subject CHRO8.I who had suspected deletions at the KCNV2 locus (Roche NimbleGen).

The deletion junctions in patients CHRO8.I and RCD307 were determined by long distance PCR amplifications and subsequent Sanger sequencing to define the precise breakpoints.

Independent segregation of the mutations within the families were conducted by Sanger sequencing of PCR amplified genomic DNA for point mutations, and by qPCR in the two families segregating the KCNV2 gene deletion.

Clinical Examination

A complete ophthalmological examination was performed including psychophysical tests (Snellen visual acuity, Lanthony Panel D-15 and Nagel anomaloscope color vision tests, visual field and dark adaptation) and an extended electrophysiological protocol (Ganzfeld and multifocal ERG).

Psychophysical testing

Kinetic 90° and static 30° visual field tests were carried out with an Octopus 900 perimeter (Haag-Streit International, Germany). Dark adaptation curves were measured with a dark adaptometer (Roland Consult GmbH, Brandenburg, Germany) after pupil dilation with Tropicamid. After 3 minutes of bleaching with bright white light (intensity 5.5 log photopic trolands), a staircase procedure was used to estimate detection thresholds over a period of 40 minutes. Thresholds were alternately measured for red (635 nm) and green (565 nm) circular targets, presented 20° nasal of the fovea. Cone and rod thresholds were then determined by a model fit using the equation:

[Formula ID: pone.0046762.e001]
with tk describing the time to the rod-cone break and I1, R1 the exponential decay of the cone, I2, R2 of the rod thresholds. Cone and rod parameters are derived from red and green target functions respectively. For group analysis and for comparison to normals the model was fitted to the raw data of each group of subjects.

Electrophysiological testing

Ganzfeld and multifocal electroretinograms ERGs were recorded according to the standards of the International Society for Clinical Electrophysiology of Vision (ISCEV) [20], [21]. All tests were performed using DTL electrodes with an Espion E2 (Diagnosys LLC) recording device coupled with a ColorDome (Diagnosys LLC) as light source. After 30 minutes of dark adaptation a series of responses to increasing flash intensities (4 ms–0.0001 cd.s/m2 to 10 cd.s/m2 in 0.5 log unit steps) were recorded and the stimulus-response (S-R) functions modelled using the equation:

[Formula ID: pone.0046762.e002]
with the saturated b-wave amplitude Vmax, the flash intensity K required for semi-saturation as a measure of retinal sensitivity and the slope related exponent n[22].

Rod response characteristics were estimated from the a-wave by the Hood and Birch (1994) formulation of the Lamb and Pugh model [23] of the biochemical processes involved in the activation of rod phototransduction. The a-wave ensemble was fitted with a computational model describing the response (PIII) as a function of time (t) and intensity (I):

[Formula ID: pone.0046762.e003]
where RmpIII is the maximum amplitude, S is a sensitivity variable and td is a brief delay before the response onset.

PIII was then subtracted from the original ERG waveform to give the PII response, which is thought to represent mainly the ON-bipolar cell response, but also the postreceptoral activity in other second- and third-order retinal neurons. The relation between flash intensity and the delay between stimulus onset and reaching a given arbitrary criterion voltage of the PII component was then plotted on a log-log coordinate and the slope of this function was calculated. The voltage criterion chosen in this study was 50 µV.

Finally, dark-adapted responses to a series of blue flicker (LED 470 nm) with an intensity of 0.03 cd.s/m2 and frequencies between 5 and 30 Hz were recorded to isolate temporal retinal characteristics of the rod system [24].

The light-adapted protocol (10 min of light adaptation to a background luminance of 30 cd/m2) included a single flash cone stimulus and a 30 Hz flicker (both: 4 ms, 3.0 cd.s/m2). In addition, responses to a series of flicker white stimuli of 3.0 cd.s/m2 with increasing frequency from 5 to 45 Hz were included to investigate possible alterations in the temporal resolution of the cone retinal pathway.

Multifocal ERG (mfERG) was performed with a VERIS System (Version 5.1) using a Grass amplifier (model 12, Quincy, USA). The stimulus, consisting of 61 scaled hexagonal elements covering a central visual field of 60×55°, was presented on a 19″ monitor at a frame rate of 75 Hz at a distance of 32 cm from the subject's eyes. The same DTL electrodes as those for the Ganzfeld recordings were used. Responses were amplified (200 000×), bandpass-filtered (10–100 Hz), and analysed according to ring averages.

Morphological testing

Color and infrared fundus photography, autofluorescence (FAF) and spectral domain OCT recordings (Heidelberg Engineering GmbH, Germany) were performed.


Results
Molecular Genetic Findings

Mutation screening and segregation analysis led to the identification of mutations in the KCNV2 gene in our patients. The genotypes of the six patients are listed in Table 1. and the mutation localization is shown in Figure 1. We observed compound heterozygous mutations in the two sib pairs (CHRO8.I and CHRO8.II, and BD27.I and BD27.II): both patients from family CHRO8 carried two compound heterozygous nonsense mutations p.Cys113stop and p.Glu148stop, while both patients of family BD27 were compound heterozygous for a complete deletion of the KCNV2 gene and a missense mutation p.Leu404Pro located in the linker between transmembrane domains S4 and S5. The simplex subject BCM5 harboured two compound heterozygous small deletions: c.8_11del and c.447_449del. The c.8_11del mutation created a frame-shift at the very beginning of the KCNV2 polypeptide, resulting in a premature stop codon and a severely altered and truncated protein (p.Lys3ArgfsX95). The other deletion only resulted in the loss of a single phenylalanine at position 150 (p.Phe150del) within the NAB domain. The last patient RCD307 was homozygous for another large deletion spanning from exon 1 into the 3′UTR. All mutations, except for the missense mutation p.Leu404Pro and the single amino acid deletion p.Phe150del (see Table 1.), are expected to result in the complete loss of Kv8.2. Consequently the siblings BD27.I and BD27.II, and patient RCD307 most likely did not express any KV8.2 gene product, causing an altered subunit composition of the respective Kv-channel and an altered or lost potassium channel function. Previous clinical data have indicated that both the complete absence of Kv8.2 (where Kv2.1 was unaffected) and its altered forms result in CDSRR [10], which suggests that the special constellation of Kv2.1/Kv8.2 heteromeric channels are essential for functionality in the photoreceptor cells. To examine whether these genotype differences are also evident in the phenotype, we divided the six patients into two groups: group 1, NOP (no protein), included the three patients with a complete absence of Kv8.2, and group 2, ALP (altered protein) with three patients with mutant Kv8.2 subunits.

Clinical Findings

Clinical findings are summarized in Table 1. All patients reported an early onset of their visual symptoms without any progression or change over the years. Only the oldest patient (RCD307) reported a slight reduction of his visual acuity in the last three years. Marked photophobia and a prolonged light adaptation time were evident in every case. Only the oldest patient complained of nyctalopia, other subjects denied having difficulty with night vision. All patients were myopic with variable degrees of astigmatism; patients of the ALP group showed a slight tendency for higher myopia and astigmatism. Four of six patients had undergone strabological surgery in childhood and two of them had suffered additionally from infantile nystagmus.

Psychophysics

All subjects presented with reduced central visual acuity (mean VA (logMAR): 0.97±0.2 SD). There was a slight tendency to poorer VA in the NOP group (1.06±0.23 SD) compared the ALP group (0.88±0.13 SD). Color vision testing using the Lanthony D-15 Panel desaturated and saturated tests and with fixation with the preferred retinal locus (PRL) showed severe color confusions in all patients predominantly along the scotopic or red-green axis with relative sparing of the tritan axis. The Rayleigh anomaloscope matches, presented eccentrically at the PRL, were consistent with a rather rod dominated function in five of six patients. Only one patient's (RCD307) results suggested protanopia. Perimetric results showed nearly normal outer boundaries of the visual field in all cases. Static perimetry results revealed relative and absolute defects in the central 30° area, being more pronounced in the NOP than the ALP group.

To test cone and rod function loss we measured dark adaptation thresholds for red and green targets. (Figure 2). All patients showed significantly elevated thresholds for red and green stimuli, although the elevation was more pronounced in the NOP group with a final rod threshold of −1.9 log cd/m2 and a cone threshold of 0.4 log cd/m2 compared to −2.6 log cd/m2 and −0.3 log cd/m2 for the rod and cone threshold in the ALP group. Thresholds estimated for normals were −1.5 log cd/m2 and −3.7 log cd/m2 for red and green stimuli, respectively. For green stimuli the rod-cone break was normal (11.0 min for the NOP and ALP group, normal: 10.7 min) and for red stimuli the rod-cone break tended to appear earlier (after 15.6 and 15.9 min for NOP and ALP respectively, normal: 16.9 min).

Electrophysiology

Basic clinical investigation included the Ganzfeld ERG according to the ISCEV standard, for which all patients showed the previously described characteristic responses (see Figure 3 for typical results of a patient from the NOP and ALP group). Most interestingly, oscillatory potentials (OPs) were almost completely absent in the patients' ERG recordings. Figure 4 shows for each subject the amplitudes and implicit times of the a- and b-waves for the scotopic response series recordings. Typical low or undetectable response amplitudes to weak flashes were evident, with markedly delayed implicit times of the a- and b-wave component. There was also an abrupt increase in amplitude with increasing flash intensity accompanied by a normalization of b-wave implicit times. While mean saturation amplitudes Vmax of the b-wave model fit were similar for both groups and normals (526 µV for normals, 528 and 493 µV for the NOP and ALP groups, respectively) the intensity K at semi-saturation was significantly shifted to higher intensities (−2.5, −1.7 and −1.7 log cd.s/m2 for normals, NOP and ALP, respectively). Additionally, the peak a-wave amplitude was normal within the entire stimulus intensity range, but the peak implicit times were prolonged for each stimulus step.

In this study the rod a-wave showed three interesting features (Figure 5.): First, in some patients the a-wave of the response to the highest intensity stimulus (4.7 log td*s) was smaller than that to the 4.2 log td*s stimulus. This is depicted for one subject in Figure 5A. While R2 of the fits in normal subjects was above 0.02 in only two eyes, it was higher in seven of the patient eyes (Figure 5B). The difference in goodness of the fit is seen in the normal subject in Figure 5C and in the representative patient BCM5 in Figure 5D.

Second, the latency of the negative deflection from baseline appeared with normal delay (average of 4.1±0.92 ms and 4.3±0.35 ms for patients and normals respectively).

And third, while the maximum response amplitude RmPIII estimated from the model fit was not different from that of normals (on average 241±71 µV and 270±83 µV for patients and normals respectively), the sensitivity parameter S was significantly lower in patients (0.73±0.38 SD) than in normals (1.14±0.36 SD).

PII responses were calculated by removal of the fitted PIII (Figure 6.). The latency at which PII reaches 50 µV is plotted as a function of stimulus intensity on log-log coordinates in Figure 6C. In the normal retina we found a slope of −0.18±0.014 SD. In patients with KCNV2 mutations the mean slopes of regression lines were not significantly different from each other or from the normal mean slope (−0.24±0.065 SD and −0.20±0.038 SD for the NOP and ALP group, respectively), however, a similar and clear shift either representing a response delay or a horizontal shift to higher intensities of approx. 1 log unit was observed in both groups. Latter was consistent with the psychophysically (dark adaptation) estimated rod threshold elevation of approx. 1 log unit.

We additionally recorded responses to various flicker frequencies under scotopic conditions (Figure 7). Magnitude (Figure 7A) and phase (Figure 7B) of the responses to increasing flicker frequencies are demonstrated. The individual data under scotopic conditions showed reduced magnitudes and a phase difference, which was independent from flicker frequency thus suggesting either a rather small constant prolongation of rod photoreceptor recovery or may result from the sensitivity reduction to the flash strength.

Cone responses recorded under photopic conditions showed a marked suppression of response amplitudes, which remained diminished even at the higher flash intensities (Figure 8.). Additionally, the amplitudes did not show a photopic hill phenomenon. Implicit times were markedly prolonged for each stimulus step. The photopic negative responses (PhNR) were almost undetectable in patients with KCNV2 mutations, as depicted in Figure 9.

As found for scotopic conditions, the photopic responses to stimuli of increasing frequency (Figure 10.) showed a similar dependency but also lower amplitudes and a shift in phase. Interestingly, even at the highest frequency of 45 Hz the response waveform was still significant with an almost normal phase.

Finally, multifocal ERGs showed reduced amplitudes and delayed implicit times in every ring (Figure 11.) being more distinct in the central 2 rings. In the outer rings more preserved responses could be obtained. The dysfunction was more sharply limited to the central two rings in the NOP group, which was not observed that clearly in the ALP group. This could be related to the slightly better VA of the ALP group.

Morphology

Fundus photographs, FAF images and OCT scans for each subject can be seen in Figure 12. There was a range of macular appearances including discrete disturbances of the retinal pigment epithelium (RPE) and bull's eye maculopathy. Patients with a complete absence of Kv8.2 (NOP group) showed more pronounced changes in the macular area, the mean central retinal thickness was 103.5 µm for the NOP, and 135.1 µm for the ALP group, respectively. In FAF imaging mild RPE-alterations were present as small areas with decreased autofluorescence. In contrast, marked RPE-atrophies were seen as sharply demarcated areas of absent autofluorescence surrounded by a ring of increased signal. The oldest patient (RCD307) revealed additional RPE-defects of the posterior pole and epiretinal gliosis. The OCT images also demonstrated the variety of morphological findings. In the milder cases –mainly in the ALP group- OCT revealed a thinner photoreceptor layer (PRL) in the foveal area, there was no disruption in the inner segment/outer segment (IS/OS) border. In the more severe cases (NOP group) the PRL was missing, the IS/OS border was diminished and an increased backscatter from the choroid was observed due to RPE-atrophy. In one case additional granular echoes were present due to deposits on the fundus of patient BD27.I. Based on the SD-OCT volume scans detected from the central 30°×15° retinal area the peripheral outer retinal structure was well preserved in every patient.


Discussion

This study describes the genotype and phenotype of six patients with a retinal dystrophy due to changes in the KCNV2 gene. In three patients the mutations resulted in a complete absence of Kv8.2 encoded by the KCNV2 gene (NOP group). In the other three patients heterozygous mutations of the first allele resulted in a lack of protein product, mutations of the second allele led to mutant subunits with presumably remaining pore function (ALP group).

On the morphological level, macular pathology varied from mild RPE disturbances to large atrophic areas, while the periphery was normal in every case. These findings are consistent with the results described by Robson et al. and Sergouniotis et al. [18], It is interesting to see that the changes are strictly limited to the central macular area in every case, while the specific functional changes of this retinal disorder affect rod-rich mid periphery as well. The question of why cones degenerate and rods keep at least their morphological integrity still remains to be unraveled, but the distribution of Müller cells in the retina (i.e. absence in the fovea) could be one important factor, since their regulatory and buffering effect on the extracellular K+ is missing in the cone-rich area, making cones more vulnerable.

Although there was a tendency for a more pronounced macular lesion (seen in the OCT and FAF imaging), higher myopia and more elevated dark adaptation thresholds in the NOP group, no clear-cut line can be drawn between the two groups. Interestingly, the only homozygous patient (RCD307) seemed to differ in a few aspects from the heterozygous patients: night blindness, protanomaly and reported progression were present only in his case. There was no family history of color disturbances in this subject and the further genetic analysis of the L-M pigment genes showed an intact OPN1MW/OPN1LW gene cluster [25], [26], indicating a severe protanomaly rather than protanopia. Furthermore, his morphological results revealed more distinct changes of the fovea resembling a macular hole on the left eye. However, the additional RPE-defects of the posterior pole, the macular hole formation and the accompanying epiretinal gliosis could be due to age related changes, explaining the decreasing visual acuity observed by the 60-year-old patient. However, the investigated cohort is small, further large studies are necessary to better highlight the correlations between genotype and phenotype.

Several studies exist on the electrophysiological characteristics of KCNV2 retinopathy. [1], [4], [6], [17], [27]. Nevertheless, there are still several aspects of this special retinal disorder, for which an explanation is needed

The lack of Kv8.2 or the presence of mutant subunits eliminates the functional characteristics of Kv2.1/Kv8.2 heteromers leading to a retinal disorder. Only the intact heteromers have the essential specifics to function as a high-pass amplifier and so regulate photoreceptor responses to light flashes. Kv2.1 can form homomeric channels, but without the intact Kv8.2 subunits they activate more slowly and inactivate faster, whereas the voltage dependence of the steady-state inactivation remains unchanged [11], [12].

The absence of intact Kv8.2 subunits therefore leads to a positive shift of the steady-state membrane potential, decreasing the dark current and elevating intracellular K+ level. Kv2.1 channels alone do not produce a permanent outward K+ current, which also affects the K+ homeostasis of the photoreceptors. While restoring the integrity of the K+ levels, secondary mechanisms can also lead to a small drop of intracellular Ca2+ levels, probably due to altered/enhanced function of the Na+/Ca2+-K+ exchanger. The small drop of cytoplasmic Ca2+, however, can result in increasing cGMP levels due to disinhibiting the activated guanylate-cyclase and finally increases the number of open cyclic nucleotide-gated channels. This shift to a more depolarized state in the dark may also have consequences for recovery: for very brief light flashes the membrane potential may remain below the critical limit of −50 mV before the hyperpolarization-activated cyclic nucleotide-gated channels (HCN channels) become activated [28], thus leading to a prolonged hyperpolarization phase. These mechanisms are well reflected in the electrophysiological findings observed in patients with KCNV2 retinopathy [4], [6], [17]. The responses are characteristically undetectable or markedly reduced with delayed implicit times for dimmer stimuli and there is an abrupt rise in amplitudes and shortening of implicit time with increasing stimulus intensity. The intensity K at semi-saturation is significantly shifted to higher intensities, the estimated difference in our cohort is around 1 log cd.s/m2. This shift correlates with the threshold elevation during dark adaptometry (for rod thresholds approximately 1 log unit elevation). However, most of our patients do not suffer from nyctalopia, confirming other reports of this inconsistency between subjective and objective light sensation [4], [23].

Our results are in accordance with previous reports and also confirm that “supernormal rod responses” in the ERG - believed to be characteristic for this rare condition - often seem to be missing, as responses, even to high intensity flashes, stay within normal limits in many cases [16], [17]. The dynamics of the b-wave intensity-response function is a more constant feature.

In addition, our detailed electrophysiological data show other specific features. The initial phase or leading edge of scotopic response waveforms reflects the activity of photoreceptor cells and arises from light-evoked closure of Na+ channels along the plasma membrane of the outer segments. Based on the model fits to our electrophysiological data we conclude that phototransduction activation in this retinal dystrophy is normal, since the onset of the deflection from baseline appears with normal delay. While the maximum amplitude RmPIII was within normal limits, the sensitivity parameter S was significantly lower. Similar results were reported for the patient described by Tanimoto et al. [29]. On the contrary, Hood et al. [4] found essentially normal sensitivity S and a slightly lower RmPIII, the maximum amplitude, for the rods. However, our patients were included in the study based on confirmed alterations of KCNV2, while patients in the study of Hood et al. were chosen on a clinical-electrophysiological basis (i.e. retinal dystrophy with supernormal rod responses). While higher RmPIII might be explained by an overshoot due to delayed HCN channel activation, lower sensitivity may be related to higher cation channel sensitivity to cGMP due to lower Ca2+ levels.

There is also a delayed postreceptoral response, which seems independent from flicker frequency. The delay of the emerging b-wave may have two different origins. Firstly, voltage dependent transmitter release may be delayed due to a small prolongation in reaching hyperpolarization. Secondly, a delayed HCN channel activation and depolarization of the photoreceptor might result in an overshoot of the response of the downstream neuron. Such overshoot would not be associated with changes in the G-protein activation cascade of the bipolar cell, which can be assessed with the PII response analysis. In our KCNV2 patients the kinetics of the ON-bipolar cell G-protein cascade seems to be normal, however, the cascade is activated with a clear delay. In the study of Robson et al. [17] including 25 patients with the characteristic scotopic b-wave signs, this delay was seen for the ON-responses and particularly for the OFF-responses as well. A further interesting finding was the marked reduction or even absence of the oscillatory potentials, either suggesting an altered function of the inner retina (i.e. amacrine or interplexiform cells) or more likely a significantly reduced cone function [28].

Moreover, we studied the temporal characteristics of the retina for the first time in this specific retinal disorder. Repetitive stimulation is very demanding for the metabolic process in neurons and changes in the temporal dynamics (e.g. in channelopathies) are evident in flicker ERGs [30]. The impairment of temporal response characteristics can occur due to photoreceptor disturbances as well as postsynaptic mechanisms. Kv2.1/Kv8.2 heteromeric channels contribute to the generation of the K+ current responsible for the dynamic signal amplification of photoreceptors. The hyperpolarizing overshoot in response to rapid onset illumination has an important role in increasing the sensitivity to fast changes of illumination. Altered Kv2.1/Kv8.2 heteromers lose their ability to function as a high-pass amplifier, which explains the altered temporal characteristics observed in our patients (i.e. there is a constant prolongation of photoreceptor recovery time). Interestingly, even at the highest frequency of 45 Hz the response waveform was still significant with an almost normal phase, which indicates that even though we find clearly reduced amplitudes and a phase shift due to cone dystrophy, the temporal dynamics seem to be almost normal. There is little known about critical flicker fusion in retinal dystrophies in humans, but it has been shown in RCS rats that with progression of the degeneration the amplitude for higher frequency waveforms declines and the critical flicker fusion frequency is shifted to lower frequencies [31]. However, Kv2.1/Kv8.2 heteromeric channels are not the only components of the outward K+ current in photoreceptors, although they are essential for their functional properties.

These special electrophysiological features are considered to be strictly associated with KCNV2 mutations, but recently Thompson et al. [32] have shown somewhat similar changes of the dark-adapted electroretinogram in patients with KCNJ10 mutations. The K+ channel expressed by the KCNJ10 gene (Kir4.1) has previously been recognized as pathogenic in man, causing a constellation of symptoms, including epilepsy, ataxia, sensorineural deafness and a renal tubulopathy (EAST syndrome). Kir4.1 constitutes the primary inward rectifying potassium channel of retinal Müller cells [33] and is responsible for the regulation of extracellular K+. Thompson et al. nicely demonstrated similar dynamics of scotopic intensity-response function in two of four patients. ERGs to dimmer flash stimuli showed a delay of up to 20 ms before the onset of the b-wave, and with increasing intensity a sudden elevation of amplitudes and normal implicit times could be detected. These similarities of the scotopic ERG could be explained with an altered sensitivity at the synapse between rod and ON-bipolar cells due to mutations in KCNJ10. Photopic ERGs of all patients showed reduced amplitudes of the photopic negative response (PhNR) and showed a delay in b-wave time to peak, but the photopic hill was preserved. However, these patients did not develop a cone dystrophy, since mutations in KCNJ10 primarily affect the Müller cell functions, while mutations in KCNV2 lead to disturbed functional integrity of the photoreceptors and probably impair their postreceptoral signaling.

KCNV2 retinopathy is considered a very rare retinal disorder associated with high but often normal mixed rod-cone response amplitudes, a marked prolongation of b-wave implicit times and a delayed, almost sudden, steep amplitude-versus-intensity relationship under scotopic conditions. Furthermore, while rod phototransduction is intact, there is a constant delay of the responses, which suggests changes in the synapse or in postreceptoral signaling pathway. Inner retinal involvement is also probable, since oscillatory potentials are almost absent. These findings are diagnostic and are exclusively linked to KCNV2 mutations.


References
1. Gouras P,, Eggers HM,, MacKay CJ, (Year: 1983) Cone dystrophy, nyctalopia, and supernormal rod responses. A new retinal degeneration. Arch Ophthalmol101: 718–7246601944
2. Alexander KR,, Fishman GA, (Year: 1984) Supernormal scotopic ERG in cone dystrophy. Br J Ophthalmol68: 69–786607068
3. Foerster MH,, Kellner U,, Wessing A, (Year: 1990) Cone dystrophy and supernormal dark-adapted b-waves in the electroretinogram. Graefes Arch Clin Exp Ophthalmol228: 116–1192186970
4. Hood DC,, Cideciyan AV,, Halevy DA,, Jacobson SG, (Year: 1996) Sites of disease action in a retinal dystrophy with supernormal and delayed rod electroretinogram b-waves. Vision Res36: 889–9018736222
5. Kato M,, Kobayashi R,, Watanabe I, (Year: 1993) Cone dysfunction and supernormal scotopic electroretinogram with a high-intensity stimulus. A report of three cases. Doc Ophthalmol84: 71–818223112
6. Michaelides M,, Holder GE,, Webster AR,, Hunt DM,, Bird AC,, et al. (Year: 2005) A detailed phenotypic study of “cone dystrophy with supernormal rod ERG”. Br J Ophthalmol89: 332–33915722315
7. Rosenberg T,, Simonsen SE, (Year: 1993) Retinal cone dysfunction of supernormal rod ERG type. Five new cases. Acta Ophthalmol (Copenh)71: 246–2558333273
8. Sandberg MA,, Miller S,, Berson EL, (Year: 1990) Rod electroretinograms in an elevated cyclic guanosine monophosphate-type human retinal degeneration. Comparison with retinitis pigmentosa. Invest Ophthalmol Vis Sci31: 2283–22871700774
9. Yagasaki K,, Miyake Y,, Litao RE,, Ichikawa K, (Year: 1986) Two cases of retinal degeneration with an unusual form of electroretinogram. Doc Ophthalmol63: 73–823015524
10. Wu H,, Cowing JA,, Michaelides M,, Wilkie SE,, Jeffery G,, et al. (Year: 2006) Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause “cone dystrophy with supernormal rod electroretinogram” in humans. Am J Hum Genet79: 574–57916909397
11. Czirjak G,, Toth ZE,, Enyedi P, (Year: 2007) Characterization of the heteromeric potassium channel formed by kv2.1 and the retinal subunit kv8.2 in Xenopus oocytes. J Neurophysiol98: 1213–122217652418
12. Beech DJ,, Barnes S, (Year: 1989) Characterization of a voltage-gated K+ channel that accelerates the rod response to dim light. Neuron3: 573–5812642011
13. Mohapatra DP,, Park KS,, Trimmer JS, (Year: 2007) Dynamic regulation of the voltage-gated Kv2.1 potassium channel by multisite phosphorylation. Biochem Soc Trans35: 1064–106817956280
14. Ben Salah S,, Kamei S,, Senechal A,, Lopez S,, Bazalgette C,, et al. (Year: 2008) Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram. Am J Ophthalmol145: 1099–110618400204
15. Thiagalingam S,, McGee TL,, Weleber RG,, Sandberg MA,, Trzupek KM,, et al. (Year: 2007) Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram. Ophthalmic Genet28: 135–14217896311
16. Wissinger B,, Dangel S,, Jagle H,, Hansen L,, Baumann B,, et al. (Year: 2008) Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci49: 751–75718235024
17. Robson AG,, Webster AR,, Michaelides M,, Downes SM,, Cowing JA,, et al. (Year: 2010) “Cone dystrophy with supernormal rod electroretinogram”: a comprehensive genotype/phenotype study including fundus autofluorescence and extensive electrophysiology. Retina30: 51–6219952985
18. Sergouniotis PI,, Holder GE,, Robson AG,, Michaelides M,, Webster AR,, et al. (Year: 2012) High-resolution optical coherence tomography imaging in KCNV2 retinopathy. Br J Ophthalmol96: 213–21721558291
19. Wissinger B,, Schaich S,, Baumann B,, Bonin M,, Jägle H,, et al. (Year: 2011) Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response. Hum Mutat32: 1398–140621882291
20. Hood DC,, Bach M,, Brigell M,, Keating D,, Kondo M,, et al. (Year: 2008) ISCEV guidelines for clinical multifocal electroretinography (2007 edition). Doc Ophthalmol116: 1–1117972125
21. Marmor MF,, Fulton AB,, Holder GE,, Miyake Y,, Brigell M,, et al. (Year: 2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol118: 69–7719030905
22. Evans LS,, Peachey NS,, Marchese AL, (Year: 1993) Comparison of three methods of estimating the parameters of the Naka-Rushton equation. Doc Ophthalmol84: 19–308223107
23. Hood DC,, Birch DG, (Year: 1994) Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci35: 2948–29618206712
24. Schatz A,, Wilke R,, Strasser T,, Gekeler F,, Messias A,, et al. (Year: 2012) Assessment of “non-recordable” electroretinograms by 9 Hz flicker stimulation under scotopic conditions. Doc Ophthalmol124: 27–3922179598
25. Sharpe LT,, Stockman A,, Jägle H,, Knau H,, Klausen G,, et al. (Year: 1998) Red, green, and red-green hybrid pigments in the human retina: correlations between deduced protein sequences and psychophysically measured spectral sensitivities. J Neurosci18: 10053–100699822760
26. Nathans J, (Year: 1989) The genes for color vision. Sci Am260: 42–492643825
27. Friedburg C,, Wissinger B,, Schambeck M,, Bonin M,, Kohl S,, et al. (Year: 2011) Long-term follow-up of the human phenotype in three siblings with cone dystrophy associated with a homozygous p.G461R mutation of KCNV2. Invest Ophthalmol Vis Sci52: 8621–862921911584
28. Barnes S, (Year: 1994) After Transduction: Response Shaping and Control of Transmission by Ion Channels of the Photoreceptor Inner Segment. Neurosci58: 447–459
29. Tanimoto N,, Usui T,, Ichibe M,, Takagi M,, Hasegawa S,, et al. (Year: 2005) PIII and derived PII analysis in a patient with retinal dysfunction with supernormal scotopic ERG. Doc Ophthalmol110: 219–22616328930
30. Heckenlively JR, Arden GB (2008) Principle and practice of clinical electrophysiology of vision.: MIT Press Cambridge, Massachusetts, London, England.
31. Pinilla I,, Lund RD,, Sauve Y, (Year: 2005) Cone function studied with flicker electroretinogram during progressive retinal degeneration in RCS rats. Exp Eye Res80: 51–5915652526
32. Thompson DA,, Feather S,, Stanescu HC,, Freudenthal B,, Zdebik AA,, et al. (Year: 2011) Altered electroretinograms in patients with KCNJ10 mutations and EAST syndrome. J Physiol589: 1681–168921300747
33. Kofuji P,, Ceelen P,, Zahs KR,, Surbeck LW,, Lester HA,, et al. (Year: 2000) Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. J Neurosci20: 5733–574010908613

Figures

[Figure ID: pone-0046762-g001]
doi: 10.1371/journal.pone.0046762.g001.
Figure 1  Structure of the Kv8.2 potassium channel and mutation sites detected in our patients.

The mutation pairs in each box represent the genetic findings of each patient. The genetic findings of the two sibling pairs are shown once, since the siblings share the same mutation constellation.



[Figure ID: pone-0046762-g002]
doi: 10.1371/journal.pone.0046762.g002.
Figure 2  Dark adaptation curves of the patients of both groups compared to normal subjects.

The left panel shows the cone (red stimuli), the right panel the rod function (green stimuli) of the NOP and ALP groups (the 95% confidence band of normal subjects is marked with grey). The threshold elevation for both target colors is biggest for two patients of the NOP group.



[Figure ID: pone-0046762-g003]
doi: 10.1371/journal.pone.0046762.g003.
Figure 3  ISCEV standard Ganzfeld ERG responses of a representative patient of each group compared to a normal subject.

Patient BD27.I in the upper panels represents the NOP group, while the result of patient BCM5 in the middle panels is an example for the ALP group. The normal subject is represented in the bottom panels. The patients' findings show the characteristic features of the scotopic ERG (dark-adapted (DA)) and the small photopic responses (light adapted (LA). Notice the missing oscillatory potentials on the rising b-wave in patients. (Color coding in each panel: red curves show results of the right eye (OD), blue curves show results of the left eye (OS)).



[Figure ID: pone-0046762-g004]
doi: 10.1371/journal.pone.0046762.g004.
Figure 4  Intensity-response function kinetics under scotopic conditions.

The single flash response a- and b-wave amplitudes (A) and implicit times (B) to increasing stimulus intensities are presented for both groups (upper subjects: NOP group, lower subjects: ALP group; the 95% confidence band of normal subjects is marked with grey). While the a-wave amplitude slowly and continuously increases, the b-wave amplitude stays low until the flash intensity reaches −2.5 log cd*s/m2. While peak implicit times of the a-wave responses are prolonged for all flash intensities, the implicit times of the b-wave approaches the normal range with increasing flash intensity.



[Figure ID: pone-0046762-g005]
doi: 10.1371/journal.pone.0046762.g005.
Figure 5  Analysis of the scotopic a-wave (PIII response).

(A) Scotopic response a-waves to increasing flash intensities show continuous increasing response amplitudes in the normal subject (full lines). The patient's responses (chain lines) also show continuous increasing amplitudes up to a flash intensity of 4.2 log td*s (green color coding), but a lower response amplitude to the flash with highest intensity (red color coding). Therefore responses to highest flash intensity were excluded from a-wave analysis. Interestingly, while R2 of the fits in normal subjects was above 0.02 in 2 eyes only, it was higher in 7 of the patient eyes (B). The difference in goodness of the fit is seen in the normal subject (C) and in the representative patient BCM5 (D).



[Figure ID: pone-0046762-g006]
doi: 10.1371/journal.pone.0046762.g006.
Figure 6  Analysis of the PII response.

Overlaid representative scotopic waveforms of a normal subject (grey lines) and patient BCM5 (chain lines) and the extracted PII components (B) are presented. The delay in implicit times to reach a threshold amplitude of 50 µV at each intensity level is plotted in a log-log diagram both for the NOP group and ALP group (C).



[Figure ID: pone-0046762-g007]
doi: 10.1371/journal.pone.0046762.g007.
Figure 7  Scotopic flicker series.

Magnitude (A) and phase (B) of scotopic flicker responses to stimuli of increasing flicker frequency are presented. Significance levels are color-coded in each figure, the 95% confidence band of normal subjects are marked with grey. The amplitudes of the patients are below normal and not significant for stimuli faster than 15 Hz. The phase shift, however, seems to be independent from flicker frequency.



[Figure ID: pone-0046762-g008]
doi: 10.1371/journal.pone.0046762.g008.
Figure 8  Intensity-response function kinetics under photopic conditions.

Photopic response b-wave amplitudes are shown in (A) and implicit times in (B), the 95% confidence band of normal subjects is marked with grey. The photopic hill phenomenon can be observed in normals, however, this phenomenon seems to be missing in patients. Implicit times in both patient groups are moderately delayed (upper subjects: NOP group, lower subjects: ALP group).



[Figure ID: pone-0046762-g009]
doi: 10.1371/journal.pone.0046762.g009.
Figure 9  Photopic negative response (PhNR).

Photopic single flash response waveforms illustrating the photopic negative response (PhNR) at increasing stimulus intensities (from top to the bottom in each panel) are shown in a normal subject (on the left) and the waveforms of two representative patients of the ALP (patient BCM5 in the middle) and NOP group (patient RCD307 on the right). Notice, that patients lack the PhNR in the given intensity range.



[Figure ID: pone-0046762-g010]
doi: 10.1371/journal.pone.0046762.g010.
Figure 10  Photopic flicker series.

Magnitude (A) and phase (B) of photopic flicker responses in a flicker series show similar frequency dependence but lower magnitude in patients accompanied by a phase shift. Significance levels are color-coded in each figure, the 95% confidence band of normal subjects is marked with grey.



[Figure ID: pone-0046762-g011]
doi: 10.1371/journal.pone.0046762.g011.
Figure 11  MfERG results.

Individual mfERG response waveforms for the subjects of each group (NOP group on the left, ALP group on the right) compared to normal subjects waveforms (black curves represent the responses of the patients, grey curves show normal responses). Responses of patients are reduced and delayed in both groups, more pronounced in the central rings. Interestingly, in the ALP group the central 2 rings tend to show more preserved responses. This could be in relation with the slightly better VA of the ALP group.



[Figure ID: pone-0046762-g012]
doi: 10.1371/journal.pone.0046762.g012.
Figure 12  Morphological findings.

Fundus photographs of the right eye, FAF and spectral domain OCT images of both eyes of six patients illustrating the variability and extent of foveal changes (NOP group: upper three patients, ALP group: lower three patients). Notice the age-related changes, epiretinal gliosis and macular hole formation on the left eye of the RCD307 patient.



Tables
[TableWrap ID: pone-0046762-t001] doi: 10.1371/journal.pone.0046762.t001.
Table 1  Clinical and genetic findings of the six patients.
Patient ID Gender Age VA (RE/LE) Refraction Night blindness Color vision Nystagmus Strabismus Alteration nucleotide sequence Alteration polypeptide Allele status
BD27.I M 36 0.125 −2.0/−1.0×145° no achromat no no c.339C>A p.Cys113X heterozygous
0.1 −1.0 c.442G>T p.Glu148X
BD27.II F 40 0.04 −3.5/−2.25×174° no achromat yes yes c.339C>A p.Cys113X heterozygous
0.05 n.A. c.442G>T p.Glu148X
RCD307* M 60 0.16 −3.5/−1.25×0° yes protanomalous no no c.19_1356+9571 delinsCATTTG Arg7fs homozygous
0.1 −1.0/−1.0×0°
CHRO8.I* M 37 0.1 −8.75/−2.0×18° no achromat yes yes g.2657638_2737340del Deletion heterozygous
0.1 −8.25/−2.0×141° c.1211T>C p.Leu404Pro
CHRO8.II* F 35 0.1 −4.5/−4.0×0° no achromat no yes g.2657638_2737340del Deletion heterozygous
0.2 −3.5/−4.0×0° c.1211T>C p.Leu404Pro
BCM5 M 28 0.16 −5.0/−1.5×2° no achromat no yes c.8_11del4 p.Lys3ArgfsX29 heterozygous
0.16 −3.5/−1.0×6° c.447_449del3 p.Phe150del

The upper three patients show a complete absence of Kv8.2 due to large deletions or protein truncating mutations of KCNV2 and so represent the NOP group. The lower three patients represent the ALP group with altered Kv8.2 subunits due to KCNV2 mutations. The BD27.I and BD27.II are brother and sister of one family, so are CHRO8.I and CHRO.II of another family. Each case shows an autosomal recessive inheritance. A considerable difference between the NOP and ALP group cannot be observed. However, there is a tendency for a slightly better visual acuity (VA) and higher myopia in the ALP group (lower three patients). Interestingly, night blindness, subjective disease progression and a severe protanomaly are present in the only homozygous patient (RCD307), while other patients reveal unchanged visual function over disease duration, no night blindness and color disturbances consistent with a rod dominated function. (Patients marked with * have been published in Wissinger et al. [19]).



Article Categories:
  • Research Article
Article Categories:
  • Biology
    • Genetics
      • Genetic Mutation
      • Genetics of Disease
    • Neuroscience
      • Sensory Systems
        • Visual System
Article Categories:
  • Medicine
    • Anatomy and Physiology
      • Ocular System
    • Ophthalmology
      • Retinal Disorders


Previous Document:  Utility of a PI3K/mTOR inhibitor (NVP-BEZ235) for thyroid cancer therapy.
Next Document:  Induced pluripotent stem cells show metabolomic differences to embryonic stem cells in polyunsaturat...